Intravitreal Injectable Market size was valued around US$ YY million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 5.8% during the forecast period (2024-2031).
Growing chronic retinal diseases and key manufacturers focusing on developing new drugs to meet patients' needs are the factors driving the market in the forecast period.